TickerFactsScreenerDevelopers

Caris Life Sciences, Inc. (CAI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$276.10M2024: -$245.20M2025: $83.16M$83.16M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$83.16M+133.9%
2024-$245.20M+11.2%
2023-$276.10M—